In vitro activity of tigecycline against carbapenemase-producing Acinetobacter baumannii

International Journal of Antimicrobial Agents

Volumn 36, Issue 3, 2010, Pages 289-290

  Hawser, Stephen P ^a   Hackel, Meredith ^b   Person, Mary B ^b   Higgins, Paul G ^c   Seifert, Harald ^c   Dowzicky, Michael ^d  

^a International Health Management Associates Europe Sàrl   (Switzerland)

^b Division of Microbiology   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEMASE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; IMIPENEM; LEVOFLOXACIN; MINOCYCLINE; TAZOBACTAM; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; BACTERIUM ISOLATE; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG SCREENING; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; ACINETOBACTER INFECTION; ANALOGS AND DERIVATIVES; BIOSYNTHESIS; COMPARATIVE STUDY; CROSS INFECTION; DRUG EFFECTS; ENZYMOLOGY; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CROSS INFECTION; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 77954951849     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.04.009     Document Type: Letter

References (7)

1. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
2. Hoban D.J., Bouchillon S.K., Dowzicky M.J. Antimicrobial susceptibility of extended-spectrum β-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial. Diagn Microbiol Infect Dis 2007, 57:423-428.
3. Higgins P.G., Dammhayn C., Hackel M., Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010, 65:233-238.
4. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 7th ed. Document M7-A7. Wayne, PA: CLSI; 2007.
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. Document M100-S19. Wayne, PA: CLSI; 2009.
6. Nicolau D.P. Management of complicated infections in the era of antimicrobial resistance: the role of tigecycline. Expert Opin Pharmacother 2009, 10:1213-1222. [Erratum in: Expert Opin Pharmacother 2009;10:1527].
7. Molina J., Colina E., Pachón J. New information about the polymyxin/colistin class of antibiotics. Expert Opin Pharmacother 2009, 10:2811-2828.